

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 4.76747000 |
| 2 | vocalization behavior (GO:0071625) | 4.60694859 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.59509486 |
| 4 | protein localization to synapse (GO:0035418) | 4.50125796 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.47685561 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.45119611 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.38759694 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.36364536 |
| 9 | barbed-end actin filament capping (GO:0051016) | 4.24170634 |
| 10 | locomotory exploration behavior (GO:0035641) | 4.18796549 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.09385455 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.03503152 |
| 13 | glutamate secretion (GO:0014047) | 3.98902804 |
| 14 | regulation of synapse structural plasticity (GO:0051823) | 3.82055998 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.79738553 |
| 16 | protein localization to endosome (GO:0036010) | 3.73923936 |
| 17 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.69005048 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 3.67963532 |
| 19 | postsynaptic membrane organization (GO:0001941) | 3.60122864 |
| 20 | exploration behavior (GO:0035640) | 3.56893457 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 3.55565442 |
| 22 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.54281921 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.47334477 |
| 24 | positive regulation of synapse maturation (GO:0090129) | 3.37330484 |
| 25 | synaptic vesicle endocytosis (GO:0048488) | 3.30887604 |
| 26 | Golgi transport vesicle coating (GO:0048200) | 3.29105746 |
| 27 | COPI coating of Golgi vesicle (GO:0048205) | 3.29105746 |
| 28 | actin filament depolymerization (GO:0030042) | 3.26157812 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.23586780 |
| 30 | neurotransmitter secretion (GO:0007269) | 3.22465626 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.22065449 |
| 32 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.21090895 |
| 33 | long-term synaptic potentiation (GO:0060291) | 3.19669521 |
| 34 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.19366050 |
| 35 | synaptic transmission, glutamatergic (GO:0035249) | 3.19313344 |
| 36 | neuron-neuron synaptic transmission (GO:0007270) | 3.15150319 |
| 37 | layer formation in cerebral cortex (GO:0021819) | 3.14886261 |
| 38 | adhesion of symbiont to host cell (GO:0044650) | 3.12467099 |
| 39 | virion attachment to host cell (GO:0019062) | 3.12467099 |
| 40 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.11365340 |
| 41 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.07951944 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.04318821 |
| 43 | mannose metabolic process (GO:0006013) | 3.03291774 |
| 44 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.02978974 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.02422537 |
| 46 | long-term memory (GO:0007616) | 3.00110088 |
| 47 | positive regulation of membrane potential (GO:0045838) | 2.96646712 |
| 48 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.95985376 |
| 49 | cellular potassium ion homeostasis (GO:0030007) | 2.95963585 |
| 50 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.95702111 |
| 51 | glycosphingolipid catabolic process (GO:0046479) | 2.94650364 |
| 52 | adhesion of symbiont to host (GO:0044406) | 2.94431851 |
| 53 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.94304564 |
| 54 | skin morphogenesis (GO:0043589) | 2.92583740 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 2.92053259 |
| 56 | apoptotic cell clearance (GO:0043277) | 2.91603498 |
| 57 | positive regulation of neurotransmitter transport (GO:0051590) | 2.89020374 |
| 58 | stress fiber assembly (GO:0043149) | 2.87710612 |
| 59 | response to auditory stimulus (GO:0010996) | 2.87689071 |
| 60 | cell adhesion mediated by integrin (GO:0033627) | 2.87026418 |
| 61 | fibril organization (GO:0097435) | 2.86223811 |
| 62 | proline transport (GO:0015824) | 2.85712288 |
| 63 | regulation of postsynaptic membrane potential (GO:0060078) | 2.85092540 |
| 64 | regulation of synaptic plasticity (GO:0048167) | 2.83135752 |
| 65 | response to pheromone (GO:0019236) | 2.82838062 |
| 66 | extracellular fibril organization (GO:0043206) | 2.80251843 |
| 67 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.80112261 |
| 68 | regulation of vesicle fusion (GO:0031338) | 2.79913171 |
| 69 | angiotensin maturation (GO:0002003) | 2.77517606 |
| 70 | regulation of synapse maturation (GO:0090128) | 2.76179929 |
| 71 | activation of protein kinase A activity (GO:0034199) | 2.75594426 |
| 72 | regulation of extracellular matrix disassembly (GO:0010715) | 2.72774038 |
| 73 | regulation of neurotransmitter transport (GO:0051588) | 2.71035488 |
| 74 | positive regulation of synaptic transmission (GO:0050806) | 2.70216170 |
| 75 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.69631993 |
| 76 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.69610520 |
| 77 | positive regulation of receptor recycling (GO:0001921) | 2.69527553 |
| 78 | auditory behavior (GO:0031223) | 2.68539206 |
| 79 | glycolipid catabolic process (GO:0019377) | 2.67623175 |
| 80 | protein retention in ER lumen (GO:0006621) | 2.64741717 |
| 81 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.62869644 |
| 82 | presynaptic membrane assembly (GO:0097105) | 2.62587730 |
| 83 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.62367511 |
| 84 | neuron recognition (GO:0008038) | 2.61474529 |
| 85 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.61443561 |
| 86 | response to histamine (GO:0034776) | 2.60935103 |
| 87 | peptide catabolic process (GO:0043171) | 2.60843504 |
| 88 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.60714780 |
| 89 | hypotonic response (GO:0006971) | 2.60058162 |
| 90 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.58465061 |
| 91 | positive regulation of extracellular matrix organization (GO:1903055) | 2.58157669 |
| 92 | learning (GO:0007612) | 2.57629081 |
| 93 | pinocytosis (GO:0006907) | 2.56224740 |
| 94 | neurotransmitter transport (GO:0006836) | 2.55708635 |
| 95 | membrane depolarization (GO:0051899) | 2.55131262 |
| 96 | positive regulation of fibroblast migration (GO:0010763) | 2.53433803 |
| 97 | sodium ion export (GO:0071436) | 2.52128489 |
| 98 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.51010246 |
| 99 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.50123483 |
| 100 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.49935589 |
| 101 | synapse assembly (GO:0007416) | 2.48782809 |
| 102 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.47684166 |
| 103 | synaptic vesicle transport (GO:0048489) | 2.47610883 |
| 104 | establishment of synaptic vesicle localization (GO:0097480) | 2.47610883 |
| 105 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.47420780 |
| 106 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.46434843 |
| 107 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.45766975 |
| 108 | dendrite morphogenesis (GO:0048813) | 2.45534433 |
| 109 | regulation of synaptic transmission (GO:0050804) | 2.44316091 |
| 110 | dopamine receptor signaling pathway (GO:0007212) | 2.43312145 |
| 111 | membrane depolarization during action potential (GO:0086010) | 2.42974917 |
| 112 | substrate-dependent cell migration (GO:0006929) | 2.42910585 |
| 113 | prepulse inhibition (GO:0060134) | 2.42692864 |
| 114 | behavioral defense response (GO:0002209) | 2.40818949 |
| 115 | behavioral fear response (GO:0001662) | 2.40818949 |
| 116 | membrane hyperpolarization (GO:0060081) | 2.40500633 |
| 117 | gamma-aminobutyric acid transport (GO:0015812) | 2.39672302 |
| 118 | cortical actin cytoskeleton organization (GO:0030866) | 2.39367811 |
| 119 | positive regulation of vesicle fusion (GO:0031340) | 2.38385974 |
| 120 | clathrin coat assembly (GO:0048268) | 2.37854617 |
| 121 | synaptic transmission (GO:0007268) | 2.37770718 |
| 122 | dendritic spine morphogenesis (GO:0060997) | 2.36656018 |
| 123 | presynaptic membrane organization (GO:0097090) | 2.36248955 |
| 124 | transmission of nerve impulse (GO:0019226) | 2.36102917 |
| 125 | transferrin transport (GO:0033572) | 2.36100361 |
| 126 | hemidesmosome assembly (GO:0031581) | 2.34833860 |
| 127 | semaphorin-plexin signaling pathway (GO:0071526) | 2.34790834 |
| 128 | synaptic transmission, dopaminergic (GO:0001963) | 2.34589081 |
| 129 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.34306953 |
| 130 | neuromuscular process controlling balance (GO:0050885) | 2.34013513 |
| 131 | endothelial cell chemotaxis (GO:0035767) | 2.33840737 |
| 132 | regulation of dendritic spine development (GO:0060998) | 2.32013111 |
| 133 | axonal fasciculation (GO:0007413) | 2.32009658 |
| 134 | regulation of early endosome to late endosome transport (GO:2000641) | 2.31412062 |
| 135 | cerebellar granule cell differentiation (GO:0021707) | 2.31075406 |
| 136 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.30701102 |
| 137 | membrane raft organization (GO:0031579) | 2.30599490 |
| 138 | cell migration in hindbrain (GO:0021535) | 2.29787280 |
| 139 | innervation (GO:0060384) | 2.29738488 |
| 140 | type B pancreatic cell proliferation (GO:0044342) | 2.27810856 |
| 141 | regulation of glutamate secretion (GO:0014048) | 2.27376970 |
| 142 | response to laminar fluid shear stress (GO:0034616) | 2.26241784 |
| 143 | cortical cytoskeleton organization (GO:0030865) | 2.25756030 |
| 144 | endocytic recycling (GO:0032456) | 2.25630017 |
| 145 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.21934408 |
| 146 | ceramide catabolic process (GO:0046514) | 2.21766733 |
| 147 | endodermal cell differentiation (GO:0035987) | 2.20975744 |
| 148 | regulation of metalloenzyme activity (GO:0048552) | 2.16617016 |
| 149 | regulation of ARF protein signal transduction (GO:0032012) | 2.16613185 |
| 150 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.15535276 |
| 151 | positive regulation of axon extension (GO:0045773) | 2.14964934 |
| 152 | cell-substrate junction assembly (GO:0007044) | 2.13386170 |
| 153 | cellular copper ion homeostasis (GO:0006878) | 2.13335685 |
| 154 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.09182420 |
| 155 | basement membrane organization (GO:0071711) | 2.08267177 |
| 156 | negative regulation of fatty acid transport (GO:2000192) | 2.07928720 |
| 157 | keratan sulfate catabolic process (GO:0042340) | 2.07725646 |
| 158 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.06357189 |
| 159 | actin filament capping (GO:0051693) | 2.05614360 |
| 160 | actin filament bundle assembly (GO:0051017) | 2.04709885 |
| 161 | actin filament bundle organization (GO:0061572) | 2.04709885 |
| 162 | cell-cell junction maintenance (GO:0045217) | 2.04371719 |
| 163 | protein targeting to plasma membrane (GO:0072661) | 2.03728647 |
| 164 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.03664358 |
| 165 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.03467706 |
| 166 | regulation of leukocyte degranulation (GO:0043300) | 2.02840292 |
| 167 | regulation of collagen metabolic process (GO:0010712) | 2.02314765 |
| 168 | response to magnesium ion (GO:0032026) | 2.02215100 |
| 169 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.01563021 |
| 170 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.01161299 |
| 171 | regulation of extracellular matrix organization (GO:1903053) | 2.01131322 |
| 172 | hyaluronan catabolic process (GO:0030214) | 2.00527334 |
| 173 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 1.98903157 |
| 174 | positive regulation of protein dephosphorylation (GO:0035307) | 1.98001519 |
| 175 | platelet degranulation (GO:0002576) | 1.97583482 |
| 176 | chondroitin sulfate catabolic process (GO:0030207) | 1.96256062 |
| 177 | cellular response to prostaglandin stimulus (GO:0071379) | 1.93944000 |
| 178 | regulation of monocyte chemotaxis (GO:0090025) | 1.93763991 |
| 179 | positive regulation of pseudopodium assembly (GO:0031274) | 1.93426491 |
| 180 | epithelial cell-cell adhesion (GO:0090136) | 1.92726611 |
| 181 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 1.92577830 |
| 182 | cell volume homeostasis (GO:0006884) | 1.91737907 |
| 183 | oligosaccharide catabolic process (GO:0009313) | 1.91300700 |
| 184 | regulation of ARF GTPase activity (GO:0032312) | 1.90623415 |
| 185 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 1.88920575 |
| 186 | regulation of cholesterol homeostasis (GO:2000188) | 1.88042068 |
| 187 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.86963169 |
| 188 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 1.86889168 |
| 189 | membrane protein ectodomain proteolysis (GO:0006509) | 1.86402234 |
| 190 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 1.86058419 |
| 191 | cellular response to nutrient (GO:0031670) | 1.85715629 |
| 192 | positive regulation of leukocyte degranulation (GO:0043302) | 1.85488979 |
| 193 | macroautophagy (GO:0016236) | 1.84897515 |
| 194 | vascular endothelial growth factor signaling pathway (GO:0038084) | 1.84200337 |
| 195 | response to progesterone (GO:0032570) | 1.83019834 |
| 196 | regulation of regulated secretory pathway (GO:1903305) | 1.82647185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.41838870 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.41315887 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.33264550 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.22651319 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.05821379 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.96795147 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.89449054 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69341837 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69341837 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.67334943 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.64061016 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63895289 |
| 13 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.60570741 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54198398 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40087330 |
| 16 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.38583411 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.37624815 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37526121 |
| 19 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.36754167 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35756188 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33666108 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.27714946 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27014192 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.24507900 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.17089721 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.15257338 |
| 27 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13600324 |
| 28 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07131237 |
| 29 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.03716812 |
| 30 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.99160353 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.96649556 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.94548809 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91979546 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84959101 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.80688774 |
| 36 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.76785746 |
| 37 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.75353761 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.72261514 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71029360 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67216367 |
| 41 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.64052569 |
| 42 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.63450570 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.60664183 |
| 44 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57979647 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57910102 |
| 46 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56042984 |
| 47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.54519213 |
| 48 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52794463 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52096745 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51245273 |
| 51 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.50129548 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49026892 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47410548 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43289521 |
| 55 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42914949 |
| 56 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.42647686 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42236299 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40591770 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40444263 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39536146 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35243520 |
| 62 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35099688 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.33651490 |
| 64 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33060979 |
| 65 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32938780 |
| 66 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.31921390 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.30773445 |
| 68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.30685601 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29751380 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29402133 |
| 71 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.28796699 |
| 72 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28321691 |
| 73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27767545 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27749776 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27655676 |
| 76 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.26886164 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25894723 |
| 78 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24832235 |
| 79 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24212147 |
| 80 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.23760123 |
| 81 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23594316 |
| 82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22718859 |
| 83 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22111169 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21869584 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.21839403 |
| 86 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21365954 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20755710 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20517302 |
| 89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20149840 |
| 90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19719649 |
| 91 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19695909 |
| 92 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19087132 |
| 93 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19061352 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18225239 |
| 95 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18015955 |
| 96 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17107425 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16335990 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15941552 |
| 99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15294920 |
| 100 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15201166 |
| 101 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.15138067 |
| 102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14832047 |
| 103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13085706 |
| 104 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12839948 |
| 105 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12597905 |
| 106 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12584731 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12429669 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12291636 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11436725 |
| 110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11310809 |
| 111 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11310117 |
| 112 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11225402 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11225402 |
| 114 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11063646 |
| 115 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09175983 |
| 116 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09166195 |
| 117 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08513291 |
| 118 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.08188542 |
| 119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07726329 |
| 120 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07723576 |
| 121 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07341254 |
| 122 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07269658 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06727487 |
| 124 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06497400 |
| 125 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06479131 |
| 126 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06100321 |
| 127 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05452307 |
| 128 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04638961 |
| 129 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04480986 |
| 130 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04026072 |
| 131 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03891168 |
| 132 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03873514 |
| 133 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03358611 |
| 134 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02965516 |
| 135 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.02573935 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02446456 |
| 137 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02229172 |
| 138 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02185421 |
| 139 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02051898 |
| 140 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02042910 |
| 141 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.01939146 |
| 142 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01758460 |
| 143 | * P68_20966046_ChIP-Seq_HELA_Human | 1.01554412 |
| 144 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00494232 |
| 145 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.99973340 |
| 146 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99804924 |
| 147 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99631750 |
| 148 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99002396 |
| 149 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.98829629 |
| 150 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98798675 |
| 151 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98798675 |
| 152 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98705563 |
| 153 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.98345235 |
| 154 | AR_19668381_ChIP-Seq_PC3_Human | 0.98074322 |
| 155 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98043087 |
| 156 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97622966 |
| 157 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97151438 |
| 158 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97080468 |
| 159 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.96873973 |
| 160 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96457361 |
| 161 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96115644 |
| 162 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95428768 |
| 163 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95316574 |
| 164 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93302844 |
| 165 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93155602 |
| 166 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92182718 |
| 167 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91342398 |
| 168 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89344366 |
| 169 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87140991 |
| 170 | STAT3_23295773_ChIP-Seq_U87_Human | 0.86835816 |
| 171 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85906300 |
| 172 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85274967 |
| 173 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83002576 |
| 174 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.82942376 |
| 175 | TCF4_23295773_ChIP-Seq_U87_Human | 0.80777324 |
| 176 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.80738133 |
| 177 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80143942 |
| 178 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79534396 |
| 179 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.79024720 |
| 180 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.78917354 |
| 181 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77636841 |
| 182 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.77558140 |
| 183 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76502041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.60023452 |
| 2 | MP0003880_abnormal_central_pattern | 3.72423284 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.59787754 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.54958920 |
| 5 | MP0009840_abnormal_foam_cell | 2.99785329 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.91388600 |
| 7 | MP0009745_abnormal_behavioral_response | 2.90832382 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.81905192 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.80979549 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.80033136 |
| 11 | MP0002064_seizures | 2.67753374 |
| 12 | MP0009046_muscle_twitch | 2.64608120 |
| 13 | MP0004270_analgesia | 2.59701956 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.41402509 |
| 15 | MP0002736_abnormal_nociception_after | 2.38802876 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.35269486 |
| 17 | MP0002822_catalepsy | 2.31997248 |
| 18 | MP0005360_urolithiasis | 2.27088066 |
| 19 | MP0005257_abnormal_intraocular_pressure | 2.24345567 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.22444618 |
| 21 | MP0003436_decreased_susceptibility_to | 2.18106119 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.11794496 |
| 23 | MP0001486_abnormal_startle_reflex | 2.08760507 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 2.05275639 |
| 25 | MP0002272_abnormal_nervous_system | 2.02875417 |
| 26 | MP0001188_hyperpigmentation | 2.02867435 |
| 27 | MP0000604_amyloidosis | 2.01505993 |
| 28 | MP0004858_abnormal_nervous_system | 1.99117919 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.92422948 |
| 30 | MP0008260_abnormal_autophagy | 1.86386305 |
| 31 | MP0001970_abnormal_pain_threshold | 1.82967968 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.77469098 |
| 33 | MP0008569_lethality_at_weaning | 1.77089007 |
| 34 | MP0001501_abnormal_sleep_pattern | 1.76963836 |
| 35 | MP0004272_abnormal_basement_membrane | 1.73723333 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.72377558 |
| 37 | MP0001984_abnormal_olfaction | 1.72223991 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.71342005 |
| 39 | MP0006082_CNS_inflammation | 1.68867575 |
| 40 | MP0005023_abnormal_wound_healing | 1.66863773 |
| 41 | MP0002067_abnormal_sensory_capabilities | 1.64279779 |
| 42 | MP0001849_ear_inflammation | 1.63388545 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.62176965 |
| 44 | MP0005623_abnormal_meninges_morphology | 1.60162352 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.59934466 |
| 46 | MP0003879_abnormal_hair_cell | 1.59195734 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.57227473 |
| 48 | MP0002184_abnormal_innervation | 1.56607219 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.56594725 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.55821534 |
| 51 | MP0000858_altered_metastatic_potential | 1.49674699 |
| 52 | MP0001542_abnormal_bone_strength | 1.49300403 |
| 53 | MP0001440_abnormal_grooming_behavior | 1.49254584 |
| 54 | MP0000343_altered_response_to | 1.48875166 |
| 55 | MP0010368_abnormal_lymphatic_system | 1.47336958 |
| 56 | MP0003828_pulmonary_edema | 1.42794256 |
| 57 | MP0006054_spinal_hemorrhage | 1.41864182 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.41637227 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.36062349 |
| 60 | MP0003724_increased_susceptibility_to | 1.35247499 |
| 61 | MP0004947_skin_inflammation | 1.34557307 |
| 62 | MP0000778_abnormal_nervous_system | 1.32325488 |
| 63 | MP0005165_increased_susceptibility_to | 1.32017144 |
| 64 | MP0000920_abnormal_myelination | 1.30914827 |
| 65 | MP0002909_abnormal_adrenal_gland | 1.30805663 |
| 66 | MP0002896_abnormal_bone_mineralization | 1.29653252 |
| 67 | MP0001958_emphysema | 1.27906191 |
| 68 | MP0002090_abnormal_vision | 1.27555359 |
| 69 | MP0003950_abnormal_plasma_membrane | 1.27303052 |
| 70 | MP0003279_aneurysm | 1.25312433 |
| 71 | MP0000767_abnormal_smooth_muscle | 1.24832701 |
| 72 | MP0001502_abnormal_circadian_rhythm | 1.24703400 |
| 73 | MP0004510_myositis | 1.24603882 |
| 74 | MP0002419_abnormal_innate_immunity | 1.24074901 |
| 75 | MP0008438_abnormal_cutaneous_collagen | 1.22032455 |
| 76 | MP0005164_abnormal_response_to | 1.21581951 |
| 77 | MP0005503_abnormal_tendon_morphology | 1.20035937 |
| 78 | MP0000955_abnormal_spinal_cord | 1.17881609 |
| 79 | MP0002882_abnormal_neuron_morphology | 1.17782738 |
| 80 | MP0003690_abnormal_glial_cell | 1.14455568 |
| 81 | MP0005386_behavior/neurological_phenoty | 1.10450692 |
| 82 | MP0004924_abnormal_behavior | 1.10450692 |
| 83 | MP0000751_myopathy | 1.09940568 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 1.09884313 |
| 85 | MP0005645_abnormal_hypothalamus_physiol | 1.09713451 |
| 86 | MP0003633_abnormal_nervous_system | 1.09668599 |
| 87 | MP0010234_abnormal_vibrissa_follicle | 1.07569448 |
| 88 | MP0005390_skeleton_phenotype | 1.07527360 |
| 89 | MP0003172_abnormal_lysosome_physiology | 1.06194626 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.04639536 |
| 91 | MP0000249_abnormal_blood_vessel | 1.04527875 |
| 92 | MP0002933_joint_inflammation | 1.04310823 |
| 93 | MP0001905_abnormal_dopamine_level | 1.03717982 |
| 94 | MP0003448_altered_tumor_morphology | 1.01988433 |
| 95 | MP0005409_darkened_coat_color | 1.01901332 |
| 96 | MP0003183_abnormal_peptide_metabolism | 1.01480589 |
| 97 | MP0010155_abnormal_intestine_physiology | 1.01082778 |
| 98 | MP0001853_heart_inflammation | 0.97270966 |
| 99 | MP0002060_abnormal_skin_morphology | 0.96730605 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.96476296 |
| 101 | MP0009384_cardiac_valve_regurgitation | 0.96377338 |
| 102 | MP0005365_abnormal_bile_salt | 0.95722444 |
| 103 | MP0005451_abnormal_body_composition | 0.94466230 |
| 104 | MP0003787_abnormal_imprinting | 0.93898192 |
| 105 | MP0003045_fibrosis | 0.92375498 |
| 106 | MP0005025_abnormal_response_to | 0.92086901 |
| 107 | MP0003075_altered_response_to | 0.91101222 |
| 108 | MP0005551_abnormal_eye_electrophysiolog | 0.90674745 |
| 109 | MP0009278_abnormal_bone_marrow | 0.89343251 |
| 110 | MP0003329_amyloid_beta_deposits | 0.88993307 |
| 111 | MP0004883_abnormal_blood_vessel | 0.88441075 |
| 112 | MP0008004_abnormal_stomach_pH | 0.87757971 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.87008094 |
| 114 | MP0003122_maternal_imprinting | 0.86210028 |
| 115 | MP0002089_abnormal_postnatal_growth/wei | 0.84326715 |
| 116 | MP0000013_abnormal_adipose_tissue | 0.84127747 |
| 117 | MP0008874_decreased_physiological_sensi | 0.83396805 |
| 118 | MP0005508_abnormal_skeleton_morphology | 0.82632979 |
| 119 | MP0004742_abnormal_vestibular_system | 0.82213378 |
| 120 | MP0002295_abnormal_pulmonary_circulatio | 0.81384515 |
| 121 | MP0001348_abnormal_lacrimal_gland | 0.79298907 |
| 122 | MP0000015_abnormal_ear_pigmentation | 0.79076559 |
| 123 | MP0003631_nervous_system_phenotype | 0.78778480 |
| 124 | MP0005275_abnormal_skin_tensile | 0.78370516 |
| 125 | MP0003795_abnormal_bone_structure | 0.78354540 |
| 126 | MP0000465_gastrointestinal_hemorrhage | 0.78077345 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.77759487 |
| 128 | MP0003303_peritoneal_inflammation | 0.77595570 |
| 129 | MP0002133_abnormal_respiratory_system | 0.76556437 |
| 130 | MP0005388_respiratory_system_phenotype | 0.76556437 |
| 131 | MP0002069_abnormal_eating/drinking_beha | 0.74785859 |
| 132 | MP0001835_abnormal_antigen_presentation | 0.74323425 |
| 133 | MP0005000_abnormal_immune_tolerance | 0.74143515 |
| 134 | MP0003634_abnormal_glial_cell | 0.73990201 |
| 135 | MP0001664_abnormal_digestion | 0.73615658 |
| 136 | MP0009764_decreased_sensitivity_to | 0.73521853 |
| 137 | MP0002152_abnormal_brain_morphology | 0.72751301 |
| 138 | MP0005499_abnormal_olfactory_system | 0.72189019 |
| 139 | MP0005394_taste/olfaction_phenotype | 0.72189019 |
| 140 | MP0001243_abnormal_dermal_layer | 0.72075365 |
| 141 | MP0000534_abnormal_ureter_morphology | 0.71114920 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.70971676 |
| 143 | MP0001299_abnormal_eye_distance/ | 0.70437260 |
| 144 | MP0009785_altered_susceptibility_to | 0.69056690 |
| 145 | MP0002998_abnormal_bone_remodeling | 0.68895714 |
| 146 | MP0004142_abnormal_muscle_tone | 0.67603503 |
| 147 | MP0005375_adipose_tissue_phenotype | 0.66919119 |
| 148 | MP0000733_abnormal_muscle_development | 0.66344698 |
| 149 | MP0001845_abnormal_inflammatory_respons | 0.65579566 |
| 150 | MP0008875_abnormal_xenobiotic_pharmacok | 0.64584281 |
| 151 | MP0001851_eye_inflammation | 0.64406903 |
| 152 | MP0003091_abnormal_cell_migration | 0.63802711 |
| 153 | MP0000681_abnormal_thyroid_gland | 0.63775508 |
| 154 | MP0004484_altered_response_of | 0.63120874 |
| 155 | MP0001529_abnormal_vocalization | 0.62091057 |
| 156 | MP0002148_abnormal_hypersensitivity_rea | 0.61986699 |
| 157 | MP0008469_abnormal_protein_level | 0.61149307 |
| 158 | MP0001177_atelectasis | 0.61063386 |
| 159 | MP0000747_muscle_weakness | 0.60245138 |
| 160 | MP0005166_decreased_susceptibility_to | 0.59996969 |
| 161 | MP0002752_abnormal_somatic_nervous | 0.59932377 |
| 162 | MP0001533_abnormal_skeleton_physiology | 0.59518313 |
| 163 | MP0000631_abnormal_neuroendocrine_gland | 0.58691971 |
| 164 | MP0004145_abnormal_muscle_electrophysio | 0.57333888 |
| 165 | MP0004885_abnormal_endolymph | 0.56327219 |
| 166 | MP0002229_neurodegeneration | 0.55566430 |
| 167 | MP0001963_abnormal_hearing_physiology | 0.55143213 |
| 168 | MP0005174_abnormal_tail_pigmentation | 0.52358126 |
| 169 | MP0005595_abnormal_vascular_smooth | 0.51542373 |
| 170 | MP0001943_abnormal_respiration | 0.51192634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.99049944 |
| 2 | Myokymia (HP:0002411) | 4.89571126 |
| 3 | Focal seizures (HP:0007359) | 4.56576832 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.36908173 |
| 5 | Febrile seizures (HP:0002373) | 4.25416944 |
| 6 | Atonic seizures (HP:0010819) | 3.83677349 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.75599582 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.75599582 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.75599582 |
| 10 | Dysostosis multiplex (HP:0000943) | 3.75324690 |
| 11 | Visual hallucinations (HP:0002367) | 3.69363796 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.64256950 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.42510705 |
| 14 | Cervical subluxation (HP:0003308) | 3.40812506 |
| 15 | Mucopolysacchariduria (HP:0008155) | 3.28024904 |
| 16 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.28024904 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.22776006 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.22776006 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.22776006 |
| 20 | Absence seizures (HP:0002121) | 3.04992704 |
| 21 | Spinal canal stenosis (HP:0003416) | 3.03075627 |
| 22 | Ankle clonus (HP:0011448) | 2.95107192 |
| 23 | Action tremor (HP:0002345) | 2.91536755 |
| 24 | Upper limb amyotrophy (HP:0009129) | 2.91073089 |
| 25 | Distal upper limb amyotrophy (HP:0007149) | 2.91073089 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 2.87885337 |
| 27 | Amyloidosis (HP:0011034) | 2.82955381 |
| 28 | Diplopia (HP:0000651) | 2.81096253 |
| 29 | Abnormality of binocular vision (HP:0011514) | 2.81096253 |
| 30 | Generalized tonic-clonic seizures (HP:0002069) | 2.77381203 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 2.74365160 |
| 32 | Dialeptic seizures (HP:0011146) | 2.70686792 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 2.68500534 |
| 34 | Axonal loss (HP:0003447) | 2.63223988 |
| 35 | Mutism (HP:0002300) | 2.62281790 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 2.60344812 |
| 37 | Hand muscle atrophy (HP:0009130) | 2.60129427 |
| 38 | Broad-based gait (HP:0002136) | 2.58553859 |
| 39 | Abnormal eating behavior (HP:0100738) | 2.58087730 |
| 40 | Thin bony cortex (HP:0002753) | 2.56939035 |
| 41 | Depression (HP:0000716) | 2.55688552 |
| 42 | Truncal ataxia (HP:0002078) | 2.55386132 |
| 43 | Hypoventilation (HP:0002791) | 2.53814882 |
| 44 | Protrusio acetabuli (HP:0003179) | 2.50352341 |
| 45 | Joint stiffness (HP:0001387) | 2.48230652 |
| 46 | Abnormal hair whorl (HP:0010721) | 2.47800804 |
| 47 | Loss of speech (HP:0002371) | 2.47774891 |
| 48 | Nuclear cataract (HP:0100018) | 2.45761459 |
| 49 | Wormian bones (HP:0002645) | 2.45619072 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.44865258 |
| 51 | Short nail (HP:0001799) | 2.38739108 |
| 52 | Gaze-evoked nystagmus (HP:0000640) | 2.38734316 |
| 53 | Polyphagia (HP:0002591) | 2.37540824 |
| 54 | Vacuolated lymphocytes (HP:0001922) | 2.36256427 |
| 55 | Hyperventilation (HP:0002883) | 2.35098677 |
| 56 | Abnormality of the nasal mucosa (HP:0000433) | 2.32714595 |
| 57 | Genetic anticipation (HP:0003743) | 2.32299070 |
| 58 | Stereotypic behavior (HP:0000733) | 2.31690674 |
| 59 | Spondylolisthesis (HP:0003302) | 2.29631147 |
| 60 | Lower limb amyotrophy (HP:0007210) | 2.28143962 |
| 61 | Broad face (HP:0000283) | 2.25352894 |
| 62 | Papilledema (HP:0001085) | 2.25298951 |
| 63 | Narrow nasal bridge (HP:0000446) | 2.24385149 |
| 64 | Absent speech (HP:0001344) | 2.19134077 |
| 65 | Arterial tortuosity (HP:0005116) | 2.19098051 |
| 66 | Vascular tortuosity (HP:0004948) | 2.18966398 |
| 67 | Torticollis (HP:0000473) | 2.18202944 |
| 68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18126857 |
| 69 | Osteolytic defects of the hand bones (HP:0009699) | 2.18126857 |
| 70 | Abnormality of macrophages (HP:0004311) | 2.15370871 |
| 71 | Hemiplegia (HP:0002301) | 2.15055169 |
| 72 | Poor eye contact (HP:0000817) | 2.14721572 |
| 73 | Dilatation of the ascending aorta (HP:0005111) | 2.13613741 |
| 74 | Aortic dissection (HP:0002647) | 2.11860444 |
| 75 | Spinal rigidity (HP:0003306) | 2.10325634 |
| 76 | Dysdiadochokinesis (HP:0002075) | 2.07938547 |
| 77 | Amblyopia (HP:0000646) | 2.07408268 |
| 78 | Peritonitis (HP:0002586) | 2.07297140 |
| 79 | Achilles tendon contracture (HP:0001771) | 2.06983793 |
| 80 | Anxiety (HP:0000739) | 2.06301206 |
| 81 | Myocardial infarction (HP:0001658) | 2.05647195 |
| 82 | Failure to thrive in infancy (HP:0001531) | 2.04839121 |
| 83 | Asymmetric septal hypertrophy (HP:0001670) | 2.04601203 |
| 84 | Impaired smooth pursuit (HP:0007772) | 2.01082200 |
| 85 | Atrophic scars (HP:0001075) | 2.00477878 |
| 86 | Purpura (HP:0000979) | 1.99729778 |
| 87 | Increased connective tissue (HP:0009025) | 1.99692110 |
| 88 | Apathy (HP:0000741) | 1.99658471 |
| 89 | Mitral regurgitation (HP:0001653) | 1.98282247 |
| 90 | Aneurysm (HP:0002617) | 1.98026607 |
| 91 | Limb dystonia (HP:0002451) | 1.97629768 |
| 92 | Progressive inability to walk (HP:0002505) | 1.96152515 |
| 93 | Malnutrition (HP:0004395) | 1.95515718 |
| 94 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.95047442 |
| 95 | Abnormality of the Achilles tendon (HP:0005109) | 1.94806489 |
| 96 | Nasal polyposis (HP:0100582) | 1.93971017 |
| 97 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93361332 |
| 98 | Diminished motivation (HP:0000745) | 1.92013261 |
| 99 | Impaired social interactions (HP:0000735) | 1.91609158 |
| 100 | Abnormal social behavior (HP:0012433) | 1.91609158 |
| 101 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.89853474 |
| 102 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.89271977 |
| 103 | Mitral stenosis (HP:0001718) | 1.89158437 |
| 104 | J-shaped sella turcica (HP:0002680) | 1.89110305 |
| 105 | Palpebral edema (HP:0100540) | 1.89056917 |
| 106 | Obstructive sleep apnea (HP:0002870) | 1.88259439 |
| 107 | Bladder diverticulum (HP:0000015) | 1.87385114 |
| 108 | Hemiparesis (HP:0001269) | 1.87137745 |
| 109 | Focal dystonia (HP:0004373) | 1.86952829 |
| 110 | Agitation (HP:0000713) | 1.85958135 |
| 111 | Dysmetric saccades (HP:0000641) | 1.85930306 |
| 112 | Blue sclerae (HP:0000592) | 1.85218975 |
| 113 | Inappropriate behavior (HP:0000719) | 1.84439398 |
| 114 | Congenital stationary night blindness (HP:0007642) | 1.84334588 |
| 115 | Exotropia (HP:0000577) | 1.83490016 |
| 116 | Cerebral aneurysm (HP:0004944) | 1.82710318 |
| 117 | Open mouth (HP:0000194) | 1.81694389 |
| 118 | Aortic aneurysm (HP:0004942) | 1.81173291 |
| 119 | Difficulty climbing stairs (HP:0003551) | 1.81009197 |
| 120 | Hemorrhage of the eye (HP:0011885) | 1.80978660 |
| 121 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.80632816 |
| 122 | Increased cerebral lipofuscin (HP:0011813) | 1.80093646 |
| 123 | Pointed chin (HP:0000307) | 1.80033414 |
| 124 | Glucose intolerance (HP:0000833) | 1.79792016 |
| 125 | Hypercortisolism (HP:0001578) | 1.79051200 |
| 126 | Large eyes (HP:0001090) | 1.78295987 |
| 127 | Striae distensae (HP:0001065) | 1.78146901 |
| 128 | Inability to walk (HP:0002540) | 1.77348350 |
| 129 | Fragile skin (HP:0001030) | 1.77028496 |
| 130 | Distal lower limb amyotrophy (HP:0008944) | 1.75369127 |
| 131 | Broad metatarsal (HP:0001783) | 1.74501823 |
| 132 | Ankle contracture (HP:0006466) | 1.74410771 |
| 133 | Shallow orbits (HP:0000586) | 1.73242327 |
| 134 | Fetal akinesia sequence (HP:0001989) | 1.72667362 |
| 135 | Vertebral compression fractures (HP:0002953) | 1.71947428 |
| 136 | Ovoid vertebral bodies (HP:0003300) | 1.71439934 |
| 137 | Excessive salivation (HP:0003781) | 1.71243167 |
| 138 | Drooling (HP:0002307) | 1.71243167 |
| 139 | Aortic regurgitation (HP:0001659) | 1.70328598 |
| 140 | Abnormality of dentin (HP:0010299) | 1.70212402 |
| 141 | Postural instability (HP:0002172) | 1.69341110 |
| 142 | Craniofacial dystonia (HP:0012179) | 1.68682909 |
| 143 | Eczematoid dermatitis (HP:0000976) | 1.67149923 |
| 144 | Menorrhagia (HP:0000132) | 1.66921423 |
| 145 | Iris hypopigmentation (HP:0007730) | 1.66644096 |
| 146 | Abnormality of complement system (HP:0005339) | 1.66480999 |
| 147 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.66228793 |
| 148 | Dysmetria (HP:0001310) | 1.66041951 |
| 149 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.65901274 |
| 150 | Premature rupture of membranes (HP:0001788) | 1.64036813 |
| 151 | Hyperparathyroidism (HP:0000843) | 1.62897257 |
| 152 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.62719167 |
| 153 | Heterochromia iridis (HP:0001100) | 1.62375337 |
| 154 | Sleep apnea (HP:0010535) | 1.62174668 |
| 155 | Flat acetabular roof (HP:0003180) | 1.60991133 |
| 156 | Hyperacusis (HP:0010780) | 1.60559923 |
| 157 | Stridor (HP:0010307) | 1.60178378 |
| 158 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.60172056 |
| 159 | Wrist flexion contracture (HP:0001239) | 1.60149141 |
| 160 | Onion bulb formation (HP:0003383) | 1.60099241 |
| 161 | Coxa vara (HP:0002812) | 1.58769030 |
| 162 | Neuronal loss in central nervous system (HP:0002529) | 1.57952363 |
| 163 | Widely spaced teeth (HP:0000687) | 1.57882413 |
| 164 | Abnormality of the acetabulum (HP:0003170) | 1.57351689 |
| 165 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.57349260 |
| 166 | Long toe (HP:0010511) | 1.57193056 |
| 167 | Bradycardia (HP:0001662) | 1.57001278 |
| 168 | Akinesia (HP:0002304) | 1.55923174 |
| 169 | Elbow flexion contracture (HP:0002987) | 1.55795384 |
| 170 | Cardiovascular calcification (HP:0011915) | 1.55537563 |
| 171 | Bowel diverticulosis (HP:0005222) | 1.55473372 |
| 172 | Femoral bowing (HP:0002980) | 1.54912594 |
| 173 | Bradykinesia (HP:0002067) | 1.54789959 |
| 174 | Scanning speech (HP:0002168) | 1.54720501 |
| 175 | Overgrowth (HP:0001548) | 1.54476205 |
| 176 | Deeply set eye (HP:0000490) | 1.53965350 |
| 177 | Absent frontal sinuses (HP:0002688) | 1.53449139 |
| 178 | Protruding tongue (HP:0010808) | 1.53334510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.68563912 |
| 2 | CASK | 3.61390293 |
| 3 | MAP3K12 | 3.36468357 |
| 4 | EPHA4 | 3.20969510 |
| 5 | TESK1 | 3.10380848 |
| 6 | ERN1 | 2.93720638 |
| 7 | MAP2K7 | 2.63558183 |
| 8 | MAP3K9 | 2.61543918 |
| 9 | MARK1 | 2.47681950 |
| 10 | MINK1 | 2.30967040 |
| 11 | RIPK4 | 2.29471220 |
| 12 | MAP3K4 | 2.27327930 |
| 13 | DAPK2 | 2.20297654 |
| 14 | LIMK1 | 2.14183749 |
| 15 | IRAK3 | 2.13973890 |
| 16 | EPHA2 | 2.01815724 |
| 17 | TESK2 | 1.99088216 |
| 18 | PRPF4B | 1.97077794 |
| 19 | DAPK1 | 1.94467702 |
| 20 | PAK6 | 1.94381683 |
| 21 | CAMKK1 | 1.80780927 |
| 22 | SIK3 | 1.72161005 |
| 23 | TAOK1 | 1.68228066 |
| 24 | FES | 1.67201789 |
| 25 | SIK1 | 1.67010661 |
| 26 | MST1R | 1.66152760 |
| 27 | EPHB1 | 1.65124769 |
| 28 | MAP2K3 | 1.62409593 |
| 29 | NTRK2 | 1.60889200 |
| 30 | CDK19 | 1.60411414 |
| 31 | SIK2 | 1.59863398 |
| 32 | MAP3K6 | 1.59741424 |
| 33 | ZAP70 | 1.59231241 |
| 34 | PTK2 | 1.53994327 |
| 35 | ICK | 1.48401893 |
| 36 | CAMKK2 | 1.47181200 |
| 37 | LMTK2 | 1.44038118 |
| 38 | TNIK | 1.41736470 |
| 39 | PLK2 | 1.40467791 |
| 40 | PAK4 | 1.39841392 |
| 41 | CDK5 | 1.38566876 |
| 42 | GRK5 | 1.38321310 |
| 43 | MAP3K3 | 1.36208887 |
| 44 | PTK2B | 1.34695805 |
| 45 | MOS | 1.33291701 |
| 46 | MET | 1.29504464 |
| 47 | MAP3K11 | 1.27731246 |
| 48 | MAPK13 | 1.27568303 |
| 49 | KSR2 | 1.26382694 |
| 50 | TTN | 1.25473842 |
| 51 | MAP3K13 | 1.22217531 |
| 52 | TNK2 | 1.19801393 |
| 53 | MAP2K4 | 1.16881908 |
| 54 | NTRK1 | 1.13779184 |
| 55 | TBK1 | 1.12789325 |
| 56 | PRKG2 | 1.06607572 |
| 57 | PDPK1 | 1.06379271 |
| 58 | TYK2 | 1.03608917 |
| 59 | KSR1 | 1.02457783 |
| 60 | TAOK2 | 1.02094597 |
| 61 | ARAF | 1.00610545 |
| 62 | NME2 | 0.97137376 |
| 63 | MAPKAPK3 | 0.95900615 |
| 64 | EPHB2 | 0.94550496 |
| 65 | CAMK1 | 0.93202323 |
| 66 | BLK | 0.93194030 |
| 67 | PIM2 | 0.91961879 |
| 68 | PRKCH | 0.91371728 |
| 69 | ABL2 | 0.89121932 |
| 70 | MARK2 | 0.88501619 |
| 71 | PRKD3 | 0.86916800 |
| 72 | PRKCG | 0.85916974 |
| 73 | STK38 | 0.85748960 |
| 74 | FER | 0.84748705 |
| 75 | ERBB3 | 0.83760690 |
| 76 | PDGFRB | 0.83619360 |
| 77 | MYLK | 0.83350209 |
| 78 | FLT3 | 0.82280089 |
| 79 | CSK | 0.82225319 |
| 80 | CDK18 | 0.81778950 |
| 81 | MAPK15 | 0.80809057 |
| 82 | CDK14 | 0.78938177 |
| 83 | PKN2 | 0.77858892 |
| 84 | CDK15 | 0.76218414 |
| 85 | SGK2 | 0.75767956 |
| 86 | DAPK3 | 0.73237411 |
| 87 | MAP3K14 | 0.72285939 |
| 88 | FGFR4 | 0.71842432 |
| 89 | RAF1 | 0.71311999 |
| 90 | PDK1 | 0.69633790 |
| 91 | PTK6 | 0.69376703 |
| 92 | SGK494 | 0.68695502 |
| 93 | SGK223 | 0.68695502 |
| 94 | CAMK2A | 0.68571503 |
| 95 | CDK11A | 0.67909723 |
| 96 | FYN | 0.67665459 |
| 97 | PHKG2 | 0.67422960 |
| 98 | PHKG1 | 0.67422960 |
| 99 | RET | 0.66999077 |
| 100 | DDR2 | 0.64140306 |
| 101 | SGK3 | 0.64019527 |
| 102 | PRKCE | 0.63850345 |
| 103 | RPS6KA2 | 0.62680759 |
| 104 | PAK3 | 0.62646549 |
| 105 | HCK | 0.62532670 |
| 106 | JAK1 | 0.62481912 |
| 107 | STK11 | 0.61938712 |
| 108 | PAK2 | 0.61819471 |
| 109 | AKT3 | 0.61399646 |
| 110 | DYRK1A | 0.60930916 |
| 111 | TXK | 0.60412384 |
| 112 | LATS2 | 0.60406151 |
| 113 | MAPK7 | 0.59621222 |
| 114 | MAP3K7 | 0.58888438 |
| 115 | CCNB1 | 0.58821531 |
| 116 | MAP3K1 | 0.58444531 |
| 117 | BMPR2 | 0.58225253 |
| 118 | KIT | 0.58125882 |
| 119 | MAP2K1 | 0.57528176 |
| 120 | MAP2K6 | 0.56875214 |
| 121 | BMX | 0.56728433 |
| 122 | SMG1 | 0.54385957 |
| 123 | PRKD2 | 0.54223798 |
| 124 | MAP3K2 | 0.54202987 |
| 125 | JAK3 | 0.54195645 |
| 126 | CAMK4 | 0.53838408 |
| 127 | DYRK1B | 0.52435292 |
| 128 | GRK7 | 0.52157941 |
| 129 | SYK | 0.51739125 |
| 130 | UHMK1 | 0.51535933 |
| 131 | HIPK2 | 0.51153845 |
| 132 | NEK9 | 0.50779765 |
| 133 | FGR | 0.49562317 |
| 134 | CAMK2G | 0.49278217 |
| 135 | CSF1R | 0.48494830 |
| 136 | CDC42BPA | 0.48079588 |
| 137 | TRIB3 | 0.47918358 |
| 138 | EEF2K | 0.46256090 |
| 139 | SGK1 | 0.46062795 |
| 140 | DMPK | 0.43580097 |
| 141 | EPHA3 | 0.43048202 |
| 142 | PRKD1 | 0.42854798 |
| 143 | MAPK12 | 0.42635232 |
| 144 | PDK2 | 0.41845892 |
| 145 | ROCK2 | 0.40119639 |
| 146 | TYRO3 | 0.39977456 |
| 147 | GSK3A | 0.39902968 |
| 148 | SRC | 0.39676788 |
| 149 | ADRBK2 | 0.37292031 |
| 150 | MATK | 0.36214539 |
| 151 | RIPK1 | 0.33164301 |
| 152 | CAMK2B | 0.32022799 |
| 153 | TGFBR2 | 0.31919646 |
| 154 | ADRBK1 | 0.30759702 |
| 155 | NEK6 | 0.30654449 |
| 156 | PDGFRA | 0.30595737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.20174491 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.96794991 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.86432682 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.85289851 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.23669428 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.17172670 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.10930127 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.06200702 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.02409841 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.02221299 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.78933078 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.74945027 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.74865896 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.68574238 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.65453729 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.63791688 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.59475193 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.51918607 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45869479 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.42818054 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.41125231 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.38950082 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.35997862 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35993723 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.35354989 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.35318047 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30778363 |
| 28 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.26994178 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26428269 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.24676802 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.24096506 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.22680737 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21736448 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.18735911 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.17659963 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17500022 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15277285 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14846912 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14187133 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.10837743 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08478660 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.07475094 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06985514 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.05327430 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.04458906 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04044508 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.02231613 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99906840 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99081917 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98729853 |
| 51 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.98518433 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97276131 |
| 53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.96946368 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96421558 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96348046 |
| 56 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.95871001 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 0.94862875 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93429027 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92902396 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91970845 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.91611957 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91553793 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90551694 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89961192 |
| 65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87581886 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.87084827 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.86288035 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85521618 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84076512 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83829854 |
| 71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83237206 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.82124149 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.81803167 |
| 74 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.80529000 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79587827 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79292685 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79289190 |
| 78 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79025709 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78974784 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.78728677 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77310493 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76580603 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.76187408 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.75455832 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.74862503 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74752073 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74667481 |
| 88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.74238585 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74068114 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73819914 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.72837313 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.71676254 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71420094 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71287813 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.71078464 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.70139967 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70133250 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69662826 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69027864 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68647327 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67701032 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67186189 |
| 103 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66952896 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65296658 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65197621 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.65192372 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65011337 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64763437 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62967650 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.62651323 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62432616 |
| 112 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61439856 |
| 113 | Melanoma_Homo sapiens_hsa05218 | 0.60985157 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60227036 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59897123 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58855314 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.58823867 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58634982 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58240221 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57388476 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56023734 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54885016 |
| 123 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54809346 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54602028 |
| 125 | Apoptosis_Homo sapiens_hsa04210 | 0.53299488 |
| 126 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52895434 |
| 127 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52316111 |
| 128 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52253863 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52203157 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52098457 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | 0.51720895 |
| 132 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49221818 |
| 133 | Bile secretion_Homo sapiens_hsa04976 | 0.48812508 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48735541 |
| 135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48107074 |
| 136 | Influenza A_Homo sapiens_hsa05164 | 0.47954270 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47591945 |
| 138 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47055730 |
| 139 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46340381 |

